Nanogen Reports 2008 Third Quarter Financial Results

Nanogen, Inc. (Nasdaq: NGEN), developer of in vitro diagnostic products, has reported its unaudited financial results for the quarter ended September 30, 2008.
Revenues for the third quarter of 2008 totaled $13.8 million, representing an increase of more than 64% from the $8.4 million reported for the same quarter in 2007. Current revenue increased 7% as compared to $12.9 million in the prior quarter.

Source: Nanogen